Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | -.--% |
|
-.--% | -.--% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nutraceutical and Pharmaceutical Products
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 55 | 11/19/11 |
Mahmoud Aziz
CHM | Chairman | - | 19/21/19 |
Danny Lee
DFI | Director of Finance/CFO | - | 14/20/14 |
Kevin Bottomley
BRD | Director/Board Member | 45 | 05/19/05 |
Jamie Lewin
BRD | Director/Board Member | 74 | 11/19/11 |
Buckley Dodds
AUD | Comptroller/Controller/Auditor | - | 26/23/26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Danny Lee
DFI | Director of Finance/CFO | - | 14/20/14 |
Jamie Lewin
BRD | Director/Board Member | 74 | 11/19/11 |
Mahmoud Aziz
CHM | Chairman | - | 19/21/19 |
Paul Chow
BRD | Director/Board Member | 59 | - |
Kevin Bottomley
BRD | Director/Board Member | 45 | 05/19/05 |
Sina Pirooz
CEO | Chief Executive Officer | 55 | 11/19/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,224,131 | 33,550,348 ( 56.65 %) | 0 | 56.65 % |
Company contact information
Genix Pharmaceuticals Corp.
1055 West Hastings Street Suite 300
V6E 2E9, Vancouver
+604-609-6198
http://www.genixpharm.com![address Genix Pharmaceuticals Corporation(GENX)](https://cdn.zonebourse.com/static/address/60342547.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+12.74% | 8.12B | |
+0.47% | 7.26B | |
-9.03% | 5.5B | |
-8.36% | 3.65B | |
-17.97% | 3.33B | |
-13.17% | 1.21B | |
-25.62% | 1.15B | |
+1.96% | 899M | |
-15.09% | 866M |
- Stock Market
- Equities
- GENX Stock
- GENX Stock
- Company Genix Pharmaceuticals Corporation